These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 20008097)

  • 21. Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
    Grozinsky-Glasberg S; Shimon I; Korbonits M; Grossman AB
    Endocr Relat Cancer; 2008 Sep; 15(3):701-20. PubMed ID: 18524947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in the systemic treatment of pancreatic neuroendocrine tumors.
    Yalcin S
    Cancer Treat Rev; 2011 Apr; 37(2):127-32. PubMed ID: 20705397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.
    Oberg K
    Curr Opin Oncol; 2012 Jul; 24(4):433-40. PubMed ID: 22510940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel therapeutic agents for the treatment of gastroenteropancreatic neuroendocrine tumors.
    Pavel ME; Wiedenmann B
    Horm Metab Res; 2011 Nov; 43(12):844-53. PubMed ID: 22105475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel anticancer agents in clinical trials for well-differentiated neuroendocrine tumors.
    Faivre S; Sablin MP; Dreyer C; Raymond E
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):811-26. PubMed ID: 21095547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?
    Nakakura EK; Venook AP; Bergsland EK
    Surg Oncol Clin N Am; 2007 Jul; 16(3):639-51, x. PubMed ID: 17606198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic chemotherapy of advanced digestive neuroendocrine tumours.
    Rougier P; Ducreux M
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S202-6. PubMed ID: 10604131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine tumors of the pancreas.
    Milan SA; Yeo CJ
    Curr Opin Oncol; 2012 Jan; 24(1):46-55. PubMed ID: 22080942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of new molecules in the treatment of advanced thyroid cancer].
    Galofré JC; Gómez-Sáez JM; Álvarez Escola C; Álvarez García E; Anda Apiñaniz E; Calleja A; Donnay S; Lucas-Martin A; Menéndez Torre E; Navarro González E; Pereg V; Pérez Corral B; Santamaría Sandi J; Riesco Eizaguirre G; Zafón Llopis C;
    Endocrinol Nutr; 2011 Oct; 58(8):381-6. PubMed ID: 21924966
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neurendocrine tumours of the appendix, colon and rectum: current surgical aspects].
    Rosato L; De Tomaa G; Mondini G; Bertone P; Fornari F; Orlassino R
    Chir Ital; 2007; 59(4):445-52. PubMed ID: 17966763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemotherapy of digestive neuroendocrine tumors].
    Rougier P; Toma C; Fabri MC; Ducreux M
    Ann Gastroenterol Hepatol (Paris); 1995; 31(2):117-20. PubMed ID: 7618833
    [No Abstract]   [Full Text] [Related]  

  • 32. Tumor angiogenesis in melanoma.
    Marneros AG
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):431-46, vii-viii. PubMed ID: 19464595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine tumors: novel approaches in the age of targeted therapy.
    Phan AT; Yao JC
    Oncology (Williston Park); 2008 Dec; 22(14):1617-23; discussion 1623-4, 1629. PubMed ID: 19198220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted Therapies in the Management of Well-Differentiated Digestive and Lung Neuroendocrine Neoplasms.
    Vijayvergia N; Dasari A
    Curr Treat Options Oncol; 2020 Oct; 21(12):96. PubMed ID: 33029680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel therapeutic strategies for neuroendocrine tumours--can eminence replace evidence?
    Zedenius J
    Acta Oncol; 2008; 47(1):3-4. PubMed ID: 17891671
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug therapy for neuroendocrine tumours].
    Tóth M
    Orv Hetil; 2013 Sep; 154(39):1556-64. PubMed ID: 24058101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on the treatment of neuroendocrine tumors.
    Bajetta E; Procopio G; Ferrari L; Catena L; Del Vecchio M; Bombardieri E
    Expert Rev Anticancer Ther; 2003 Oct; 3(5):631-42. PubMed ID: 14599087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular radiotherapy with somatostatin analogs for (neuro-)endocrine tumors.
    Krenning EP; Teunissen JJ; Valkema R; deHerder WW; deJong M; Kwekkeboom DJ
    J Endocrinol Invest; 2005; 28(11 Suppl International):146-50. PubMed ID: 16625865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin.
    Gonzalez MA; Biswas S; Clifton L; Corrie PG
    Br J Cancer; 2003 Aug; 89(3):455-6. PubMed ID: 12888810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigational drugs for neuroendocrine tumours.
    Granberg D
    Expert Opin Investig Drugs; 2009 May; 18(5):601-8. PubMed ID: 19388877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.